Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,443,181
+$1,801,083 QoQ
Shares Held
69,318
-3.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#669
of 4,153 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 2%
Shared 27%
None 71%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Regal Investment Advisors LLC holds $56,143,765 across 10 Drug Manufacturers - General names. ABBV ranks #1 (31.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
69,318 | $17,443,181 | |
| 2 | JNJ |
Johnson & Johnson
|
65,349 | $16,596,685 | |
| 3 | PFE |
Pfizer Inc
|
378,806 | $9,121,648 | |
| 4 | LLY |
ELI LILLY & Co
|
4,324 | $5,186,335 | |
| 5 | MRK |
Merck & Co., Inc.
|
26,367 | $3,388,159 | |
| 6 | AMGN |
Amgen Inc
|
4,280 | $1,549,873 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,352 | $942,202 | |
| 8 | NVS |
Novartis AG
|
5,361 | $840,175 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,443,181 | 69,318 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,642,098 | 71,921 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,539,705 | 72,387 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,456,705 | 71,075 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,611,820 | 78,719 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $16,316,789 | 77,877 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $20,396,228 | 114,779 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,067,797 | 111,747 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,700,997 | 109,031 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $19,306,788 | 106,023 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,313,868 | 111,724 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,858,089 | 113,096 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,638,549 | 108,651 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $17,603,691 | 110,458 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $16,658,112 | 103,076 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $13,371,208 | 99,629 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $14,469,637 | 94,474 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $15,113,515 | 93,230 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $13,441,970 | 99,276 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,003,710 | 102,009 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $11,253,524 | 99,907 | Shares | Sole | 2021-08-09 | |
| 2020-12-31 | $12,104,521 | 112,968 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||